Allchem Lifescience
MAINBOARD
Min. Investment
Issue size
₹0 Cr
GMP
Locked
Current subscription status: --
Expert verdict
Subscription (as on 21 October 2026, 04:03 PM)
Overall-
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
- Allchem Lifescience is an Indian company founded in 2003 by Mr. Bipin Patel, specializing in the manufacture of advanced pharmaceutical intermediates (API intermediates) and specialty chemicals. Headquartered in Vadodara, Gujarat, Allchem Lifescience operates ISO-certified facilities and focuses on serving pharmaceutical, agrochemical, and industrial clients both in India and internationally across over 20 countries.
Issue Details & Objective
Face value
₹1 per share
FAQs
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
The issue size of Allchem Lifescience IPO is ₹0 Cr
The Allchem Lifescience IPO will be open for applications from null to null
The lot size of Allchem Lifescience IPO is null and its minimum investment amount is null.
